Efficacy and safety of oral mega pulse methylprednisolone for severe therapy resistant Alopecia areata

Saudi Medical Journal

Volumn 33, Issue 3, 2012, Pages 284-291

  Saif, Ghada A Bin ^a   Al Khawajah, Marwan M ^a   Al Otaibi, Hend M ^a   Al Roujayee, Abdulaziz S ^a,b   Alzolibani, Abdullateef A ^c   Kalantan, Hatem A ^a   Al Sheikh, Omar A ^a   Arafah, Maha M ^a  

^a QASSIM UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c AL IMAM MOHAMMAD IBN SAUD ISLAMIC UNIVERSITY IMSIU   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE;

ABDOMINAL PAIN; ACNE; ADULT; ALOPECIA AREATA; ANXIETY DISORDER; ARTHRALGIA; ARTICLE; ATOPY; AUTOIMMUNE THYROIDITIS; BLURRED VISION; BONE PAIN; CATARACT; CLINICAL ARTICLE; CLINICAL TRIAL; DECREASED APPETITE; DIABETES MELLITUS; DISEASE SEVERITY; DIZZINESS; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; EPIGASTRIC PAIN; FATIGUE; FEMALE; FLUSHING; FOLLOW UP; HEADACHE; HEART PALPITATION; HEARTBURN; HICCUP; HUMAN; HYPERLIPIDEMIA; HYPOTHYROIDISM; INCREASED APPETITE; IRRITABILITY; LETHARGY; MALE; MENSTRUATION DISORDER; MOOD CHANGE; MUSCLE CRAMP; NAUSEA; ONSET AGE; PARESTHESIA; PNEUMONIA; PROSPECTIVE STUDY; PRURITUS; RELAPSE; SIDE EFFECT; SINGLE BLIND PROCEDURE; SKIN INFECTION; SLEEP DISORDER; STEROID THERAPY; STRIA; SWEATING; TASTE DISORDER; TREATMENT RESPONSE; WEIGHT GAIN;

ADOLESCENT; ADULT; ALOPECIA AREATA; DRUG ADMINISTRATION ROUTES; FEMALE; HUMANS; MALE; METHYLPREDNISOLONE; YOUNG ADULT;

EID: 84858967050     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. McDonagh AJ, Tazi-Ahnini R. Epidemiology and genetics of alopecia areata. Clin Exp Dermatol 2002; 27: 405-409.
2. Galán-Gutiérrez M, Rodríguez-Bujaldón A, Moreno-Giménez JC. [Update on the treatment of alopecia areata]. Actas Dermosifiliogr 2009; 100: 266-276. Spanish
3. Garg S, Messenger AG. Alopecia areata: evidence-based treatments. Semin Cutan Med Surg 2009; 28: 15-18.
4. Burton JL, Shuster S. Large doses of glucocorticoid in the treatment of alopecia areata. Acta Derm Venereol 1975; 55: 493-496.
5. Seiter S, Ugurel S, Tilgen W, Reinhold U. High-dose pulse corticosteroid therapy in the treatment of severe alopecia areata. Dermatology 2001; 202: 230-234.
6. Friedli A, Salomon D, Saurat JH. High-dose pulse corticosteroid therapy: is it indicated for severe alopecia areata? Dermatology 2001; 202: 191-192.
7. Hayball PJ, Cosh DG, Ahern MJ, Schultz DW, Roberts- Thomson PJ. High dose oral methylprednisolone in patients with rheumatoid arthritis: pharmacokinetics and clinical response. Eur J Clin Pharmacol 1992; 42: 85-88.
8. Sabir S, Werth VP. Pulse glucocorticoids. Dermatol Clin 2000; 18: 437-446.
9. Hirano T, Oka K, Takeuchi H, Sakurai E, Matsuno N, Tamaki T, et al. Clinical significance of glucocorticoid pharmacodynamics assessed by antilymphocyte action in kidney transplantation. Marked difference between prednisolone and methylprednisolone. Transplantation 1994; 57: 1341-1348.
10. Hirano T, Oka K, Takeuchi H, Sakurai E, Kozaki K, Matsuno N, et al. A comparison of prednisolone and methylprednisolone for renal transplantation. Clin Transplant 2000; 14: 323-328.
11. Metz LM, Sabuda D, Hilsden RJ, Enns R, Meddings JB. Gastric tolerance of high-dose pulse oral prednisone in multiple sclerosis. Neurology 1999; 53: 2093-2096.
12. Assouly P, Reygagne P, Jouanique C, Matard B, Marechal E, Reynert P, et al. [Intravenous pulse methylprednisolone therapy for severe alopecia areata: an open study of 66 patients]. Ann Dermatol Venereol 2003; 130: 326-330. French
13. Agarwal A, Nath J, Barua KN. Twice weekly 5 mg betamethasone oral pulse therapy in the treatment of alopecia areata. J Eur Acad Dermatol Venereol 2006; 20: 1375-1376.
14. Ait Ourhroui M, Hassam B, Khoudri I. Treatment of alopecia areata with prednisone in a once-monthly oral pulse. Ann Dermatol Venereol 2010; 137: 514-518.
15. Tsai YM, Chen W, Hsu ML, Lin TK. High-dose steroid pulse therapy for the treatment of severe alopecia areata. J Formos Med Assoc 2002; 101: 223-226.
16. Al-Khawajah M. Alopecia areata and associated diseases in Saudi patients. Ann Saudi Med 1991; 11: 651-654.
17. Goh C, Finkel M, Christos PJ, Sinha AA. Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history. J Eur Acad Dermatol Venereol 2006; 20: 1055-1060.
18. Barahmani N, Schabath MB, Duvic M; National Alopecia Areata Registry. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol 2009; 61: 581-591.
19. Sotiriadis D, Patsatsi A, Lazaridou E, Kastanis A, Vakirlis E, Chrysomallis F. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata. Clin Exp Dermatol 2007; 32: 48-51.
20. MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG; British Association of Dermatologists. Guidelines for the management of alopecia areata. Br J Dermatol 2003; 149: 692-699.
21. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2000; 42: 549-566.
22. Im M, Lee SS, Lee Y, Kim CD, Seo YJ, Lee JH, et al. Prognostic factors in methylprednisolone pulse therapy for alopecia areata. J Dermatol 2011; 38: 767-772.
23. Kar BR, Handa S, Dogra S, Kumar B. Placebo-controlled oral pulse prednisolone therapy in alopecia areata. J Am Acad Dermatol 2005; 52: 287-290.
24. Nakajima T, Inui S, Itami S. Pulse corticosteroid therapy for alopecia areata: study of 139 patients. Dermatology 2007; 215: 320-324.
25. Kurosawa M, Nakagawa S, Mizuashi M, Sasaki Y, Kawamura M, Saito M, et al. A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata. Dermatology 2006; 212: 361-365.
26. Hubiche T, Léauté-Labrèze C, Taïeb A, Boralevi F. Poor long term outcome of severe alopecia areata in children treated with high dose pulse corticosteroid therapy. Br J Dermatol 2008; 158: 1136-1137.
27. Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 2010; 62: 177-188.
28. El-Dars LD, Kamath S, Logan R. Targetoid pattern of hair regrowth in alopecia areata: a case report. Clin Exp Dermatol 2009; 34: 413.
29. Klein-Gitelman MS, Pachman LM. Intravenous corticosteroids: adverse reactions are more variable than expected in children. J Rheumatol 1998; 25: 1995-2002.